Ishares Plc Res Nl Ord


By |


Liquidia Technologies Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain.

Contact Information

Main Phone: +1 919 328-4400
Address: 419 Davis Drive
Address 2: Suite 100
State: NC
City / Town: Morrisville
Country: USA
Postal Code: 60301

Issuer Information

Exchange: OTO
CEO: Neal F. Fowler
Employees: 60
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 107.50 $ 0.90 (0.84%)
Last Price 107.50 Change $ 0.90 Change % 0.84 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 107.50 High 107.50 Low 107.50 Prev Close 106.60
Last Trade Volume 4,704 52 Wk Hi 117.99 52 Wk Low 106.27
Market Cap 1.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 15,431,950.00 EPS (TTM) -9.25 PE Ratio N/A Exchange OTCPK